Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s)
- PMID: 28771838
- DOI: 10.1111/xen.12326
Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s)
Abstract
Background: For xenotransplantation to truly succeed, we must develop immunomodulatory strategies to suppress the xenoimmune response but by minimizing immunosuppression over the long term. Regulatory macrophages (Mreg) have been shown to suppress polyclonal T-cell proliferation in vitro and prolong allograft survival in vivo. However, the question of whether they are capable of suppressing xenoimmune responses remains unknown. This study assessed the potential of human Mreg to be used as an effective immunomodulatory method in xenotransplantation.
Methods: CD14+ monocytes selected from human peripheral blood mononuclear cells (PBMC) were cultured with macrophage colony-stimulating factor (M-CSF) for 7 days with IFN-γ added at day 6 for Mreg induction. Mreg phenotyping was performed by flow cytometric analysis, and the in vitro suppressive function was assessed by mixed lymphocyte reaction (MLR) using irradiated pig PBMC as the xenogeneic stimulator cells, human PBMC as responder cells, and autologous Mreg as suppressor cells. To assess mRNA expression of Mreg functional molecules indoleamine-2,3-dioxygenase (IDO), IL-10, inducible nitric oxide synthase (iNOS) and TGF-β were measured by real-time PCR. Supernatants were collected from the MLR cultures for IDO activity assay by high-performance liquid chromatography (HPLC). The effects of the IDO inhibitor 1-D/L-methyl-tryptophan (1-MT), iNOS inhibitor NG -monomethyl-l-arginine (L-NMMA), and anti-IFN-γ or anti-TGF-β monoclonal antibody (mAb) treatment on Mreg suppressive capacity were tested from the supernatants of the MLR assays.
Results: We demonstrated that induced Mreg with a phenotype of CD14low CD16-/low CD80low CD83-/low CD86+/hi HLA-DR+/hi were capable of suppressing proliferating human PBMC, CD4+, and CD8+ T cells, even at a higher responder:Mreg ratio of 32:1 in a pig-human xenogeneic MLR. The strong suppressive potency of Mreg was further correlated with their upregulated IDO expression and activity. The IDO upregulation of Mreg was associated with an increased production of IFN-γ, an IDO stimulator, by xenoreactive responder cells in the xenogeneic MLR. While no effect on Mreg suppressive potency was detected by addition of the iNOS inhibitor L-NMMA or anti-TGF-β mAb into the MLR assays, inhibition of IDO activity by neutralizing IFN-γ or by IDO inhibitor 1-MT substantially impaired the capacity of Mreg to suppress the xenogeneic response, indicating the importance of upregulated IDO activity in Mreg-mediated suppression of the xenogeneic response in vitro.
Conclusion: This study demonstrates that human Mreg are capable of suppressing the xenoimmune response in vitro via IDO-involved mechanism(s), suggesting their potential role as an effective immunomodulatory tool in xenotransplantation.
Keywords: indoleamine-2,3-dioxygenase; regulatory macrophages; transplantation tolerance; xenotransplantation.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells.Transplantation. 2014 Jan 15;97(1):30-8. doi: 10.1097/TP.0b013e3182a860fa. Transplantation. 2014. PMID: 24092378
-
Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration.Stem Cell Res Ther. 2017 Apr 26;8(1):101. doi: 10.1186/s13287-017-0550-1. Stem Cell Res Ther. 2017. PMID: 28446226 Free PMC article.
-
Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.Int Immunol. 2014 Dec;26(12):673-84. doi: 10.1093/intimm/dxu077. Epub 2014 Jul 26. Int Immunol. 2014. PMID: 25064493
-
Indoleamine 2,3-dioxygenase in transplantation.Nephrology (Carlton). 2008 Jun;13(3):204-11. doi: 10.1111/j.1440-1797.2007.00921.x. Epub 2008 Jan 23. Nephrology (Carlton). 2008. PMID: 18221253 Review.
-
IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism.Adv Exp Med Biol. 1999;467:517-24. doi: 10.1007/978-1-4615-4709-9_64. Adv Exp Med Biol. 1999. PMID: 10721095 Review.
Cited by
-
Immunometabolism of Liver Xenotransplantation and Prospective Solutions.Adv Sci (Weinh). 2025 Mar;12(9):e2407610. doi: 10.1002/advs.202407610. Epub 2025 Feb 6. Adv Sci (Weinh). 2025. PMID: 39912334 Free PMC article. Review.
-
Innate immune cellular therapeutics in transplantation.Front Transplant. 2023;2:1067512. doi: 10.3389/frtra.2023.1067512. Epub 2023 Mar 31. Front Transplant. 2023. PMID: 37994308 Free PMC article.
-
Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses.Front Immunol. 2020 Oct 22;11:574447. doi: 10.3389/fimmu.2020.574447. eCollection 2020. Front Immunol. 2020. PMID: 33193362 Free PMC article.
-
The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection.Front Immunol. 2021 Feb 24;12:625998. doi: 10.3389/fimmu.2021.625998. eCollection 2021. Front Immunol. 2021. PMID: 33717141 Free PMC article. Review.
-
Role of Human Macrophage Polarization in Inflammation during Infectious Diseases.Int J Mol Sci. 2018 Jun 19;19(6):1801. doi: 10.3390/ijms19061801. Int J Mol Sci. 2018. PMID: 29921749 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials